-
Women with diabetes may be at risk for hearing loss, research finds
DETROIT — Female diabetes patients may experience a greater degree of hearing loss as they get older, particularly if their condition is not well-controlled by medication, according to a new study conducted at Henry Ford Hospital in Detroit.
-
FDA approves Lilly-Boehringer Ingelheim diabetes drug
INDIANAPOLIS — The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.
The FDA approved Jentadueto (linagliptin and metformin) tablets, designed to be taken twice daily. The approval marks the second since the two companies announced their collaboration to develop diabetes drugs in January 2011; the first drug approved under the Lilly-BI partnership was Tradjenta (linagliptin), approved in May 2011.